Noninvasive assessment of gastric emptying by near-infrared fluorescence reflectance imaging in mice: Pharmacological validation with tegaserod, cisapride, and clonidine

Molecular Imaging

Volumn 3, Issue 4, 2004, Pages 303-311

  Gremlich, Hans Ulrich ^a   Martínez, Vicente ^a   Kneuer, Rainer ^a   Kinzy, Willy ^a   Weber, Eckhard ^a   Pfannkuche, Hans Juergen ^a   Rudin, Markus ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cisapride; Clonidine; Fluorescence reflection imaging; Fluorescent dyes; Gastric emptying; In vivo imaging; Near infrared imaging; Serotonin; Serotonin receptors; Tegaserod

Indexed keywords

CARBON DIOXIDE; DYES; ENZYME KINETICS; FLUORESCENCE; IMAGING TECHNIQUES; LIGHT ABSORPTION; LIGHT REFLECTION; METABOLISM; PH EFFECTS; PHARMACODYNAMICS; PHYSIOLOGY; SURGERY; TISSUE;

CISAPRIDE; CLONIDINE; FLUORESCENCE REFLECTION IMAGING (FRI); FLUORESCENT DYES; GASTRIC EMPTYING; IN VIVO IMAGING; NEAR-INFRARED IMAGING; SEROTOIN RECEPTORS; SEROTONIN; TEGASEROD;

NONINVASIVE MEDICAL PROCEDURES;

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBOCYANINE; CISAPRIDE; CLONIDINE; CY5.5 CYANINE DYE; FLUORESCENT DYE; INDOLE DERIVATIVE; SEROTONIN AGONIST; TEGASEROD;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DRUG EFFECT; FLUORESCENCE; MALE; MOUSE; STOMACH EMPTYING; VALIDATION STUDY;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CARBOCYANINES; CISAPRIDE; CLONIDINE; FLUORESCENCE; FLUORESCENT DYES; GASTRIC EMPTYING; INDOLES; MALE; MICE; MICE, INBRED BALB C; SEROTONIN AGONISTS;

EID: 13844281129     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/1535350042973490     Document Type: Article

References (32)

1. Weissleder R (2001). A clearer vision for in vivo imaging. Nat Biotechnol. 19:316-317.
2. Marten K, Bremer C, Khazaie K, Sameni M, Sloane B, Tung CH, Weissleder R (2002). Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology. 122:406-414.
3. Bremer C, Mustafa M, Bogdanov A Jr, Ntziachristos V, Petrovsky A, Weissleder R (2003). Steady-state blood volume measurements in experimental tumors with different angiogenic burdens - a study in mice. Radiology. 226:214-220.
4. Jaffer FA, Tung CH, Gerszten RE, Weissleder R (2002). In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vasc Biol. 22:1929-1935.
5. Mahmood U, Tung CH, Tang Y, Weissleder R (2002). Feasibility of in vivo multichannel optical imaging of gene expression: Experimental study in mice. Radiology. 224:446-451.
6. Rudin M, Weissleder R (2003). Molecular imaging in drug discovery and development. Nat Rev Drug Discov. 2:123-131.
7. Zaheer A, Lenkinski RE, Mahmood A, Jones AG, Cantley LC, Frangioni JV (2001). In vivo near-infrared fluorescence Imaging of osteoblastic activity. Nat Biotechnol. 19:1148-1154.
8. Martinez V, Rivier JE, Tache Y (1999). Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats. J Pharmacol Exp Ther. 290:629-634.
9. Martinez V, Wang L, Rivier JE, Vale W, Tache Y (2002). Differential actions of peripheral corticotrophin-releasing factor (CRF), urocortin II and Urocortin III on gastric emptying and colonic transit in mice: Role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther. 301:611-617.
10. Wang L, Martinez V, Rivier JE, Tache Y (2001). Peripheral urocortin inhibits gastric emptying and food intake: Differential role of CRF receptor 2. Am J Physiol. 281:R1401-R1410.
11. Kaneko H, Mitsuma T, Uchida K, Nagai H, Harada M, Kotera H (1995). Nizatidine accelerates gastric emptying of a solid meal in rats. Dig Dis Sci. 40:2043-2051.
12. 13C]-octanoic acid breath test. Clin Exp Pharmacol Physiol. 27:671-675.
13. Symonds E, Butler R, Omari T (2002). Non-invasive breath tests can detect alterations in gastric emptying in the mouse. Eur J Clin Invest. 32:341-344.
14. 13C-octanoic acid breath test: Validation of a new non-invasive method of measuring gastric emptying in rats. Neurogastroenterol Mot. 14:287-293.
15. Wiseman LR, Faulds D (1994). Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs. 47:116-152.
16. Fiomaronti J, Million M, Bueno L (1998). Investigations on a 5HT4 agonist (SDZ HTF 919) and its main metabolite in conscious dogs: Effects on gastrointestinal motility and impaired gastric emptying. Gastroenterology. 114:A752 [abstract].
17. Pfannkuche HJ, Buhl T, Gamse R, Hoyer D, Mattes H, Buchheit KH (1995). The properties of a new prokinetically active drug, SDZ HTF 919. Neurosgastroenterol Mot. 7:280 [abstract].
18. Mathis C, Lacy BE, Yu S, Nass P, Crowell MD (2001). Tegaserod maleate, a highly selective 5-HT4 receptor partial agonist, accelerates gastric emptying in a murine model of diabetic gastroparesis. Neurogastroenterol Mot. 13:412 [abstract].
19. Degen L, Matzinger D, Merz M, Appel-Dingemanse S, Osborne S, Luchinger S, Bertold R, Maecke H, Beglinger C (2001). Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther. 15:1745-1751.
20. Asai T, Vickers MD, Power I (1997). Clonidine inhibits gastric motility in the rat. Eur J Anaesthesiol. 14:316-319.
21. Ramjiawan B, Maiti P, Aftanas A, Kaplan H, Fast D, Mantsch HH, Jackson M (2000). Non-invasive localization of tumors by immunofluorescence imaging using a single chain Fv fragment of a human monoclonal antibody with broad cancer specificity. Cancer. 89:1134-1144.
22. Hanock W, Battersby J (1976). A new micro-test for the detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitrobenzenesulphonic acid. Anal Biochem. 71:260-264.
23. He G, Shankar RA, Chzhan M, Samouílov A, Kuppusamy P, Zweier JL (1999). Noninvasive measurement of anatomic structure and intraluminal oxygenation in the gastrointestinal tract of living mice with spatial and spectral EPR imaging. Proc Natl Acad Sci. 96:4586-4591.
24. Yamano M, Kamato T, Nagakura Y, Miyata K (1997). Effects of gastroprokinetic agents on gastroparesis in streptozotocin diabetic rats. Naunyn-Schmiedeberg's Arch Pharmacol. 356:145-150.
25. Tanaka T, Mizumoto A, Mochiki E, Suzuki H, Itoh Z, Omura S (1998). Effects of EM574 and cisapride on gastric contractile and emptying activity In normal and drug-induced gastroparesis in dogs. J Pharmacol Exp Ther. 287:712-719.
26. Bennink RJ, De Jonge WJ, Symonds EL, van den Wijngaard RM, Spijkerboer AL, Benninga MA, Boeckxstaens GE (2003). Validation of gastric-emptying scintigraphy of solids and liquids in mice using dedicated animal pinhole scintigraphy. J Nucl Med. 44: 1099-1104.
27. De Winter BY, Bredenoord AJ, De Man JG, Moreels TG, Herman AG, Pelckmans PA (2002). Effect of inhibition of inducible nitric oxide synthase and guanylyl cyclase on endotoxin-lnduced delay in gastric emptying and intestinal transit In mice. Shock. 18: 125-131.
28. Suchitra AD, Dkhar SA, Shewade DG, Shashindran CH (2002). Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice. World J Gastroenterol. 9. 779-783.
29. Anderson DL, Bartholomeusz FD, Kirkwood ID, Chatterton BE, Summersides G, Penglis S, Kuchel T, Sansom L (2002). Liquid gastric emptying in the pig: Effect of concentration of inhaled isoflurane. J Nucl Med. 43:968-971.
30. Schurizek BA, Willacy LH, Kraglund K, Andreasen F, Juhl B (1989). Effects of general anaesthesia with enflurane on antroduodenal motility, pH and gastric emptying rate in man. Eur J Anaesthesiol. 6:265-279.
31. Huilgol V, Evans J, Hellman RS, Soergel KH (2002). Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls. Aliment Pharmacol Ther. 16:945-950.
32. Asai T, McBeth C, Stewart JI, Williams J, Vaughan RS, Power I (1997). Effect of clonidine on gastric emptying of liquids. Br J Anaesth. 78:28-33.